Target intelligence / Profile preview

Host pattern recognition and barrier systems

Molecular classification
Receptor, Enzyme, Structural protein, Other
01

Overview

Host pattern recognition and barrier systems refers to the integrated biological network responsible for the initial detection of pathogens and the maintenance of physical separation between the host and the environment. This system comprises physical barriers, such as epithelial layers and tight junction proteins, alongside molecular sensors known as pattern recognition receptors (PRRs) [1][2]. PRRs include families such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) [1][2]. These components work synergistically to identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [3]. Upon detection, they trigger downstream signaling pathways like NF-κB and IRFs to initiate an innate immune response [4]. While not a single molecular target, various components within this system are targeted by drugs to modulate immunity or repair tissue integrity. For instance, TLR agonists are used as vaccine adjuvants or cancer immunotherapies, while barrier-modulating agents are explored for treating inflammatory bowel diseases [5][6]. Dysregulation of these systems is a hallmark of infectious diseases, chronic inflammatory conditions, and certain cancers [2][5]. The system as a whole represents the foundational architecture of innate immunity and tissue homeostasis.

Other names
Innate immune sensing and epithelial barriersMucosal barrier and PRR systemHost defense systems
02

Mechanism of action

Agonism or antagonism of pattern recognition receptors (PRRs) to modulate innate immunity, and stabilization or repair of epithelial barrier integrity through tight junction modulation.

03

Biological functions

Immune responseSignal transductionCell-cell adhesionDefense response
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerInflammatory bowel disease
05

Safety considerations

Cytokine release syndromeAutoimmune reactionsSystemic inflammatory response syndrome (SIRS)Impaired wound healing
06

Interacting drugs

Imiquimod

9 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor Necrosis Factor-alpha (TNF-α)C-reactive protein (CRP)Fecal calprotectinZonulin

Beyond the preview

Go deeper on Host pattern recognition and barrier systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host pattern recognition and barrier systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call